Develops precision probiotics designed to detoxify per- and polyfluoroalkyl substances (PFAS) from contaminated environments. This bioremediation approach targets the persistent and harmful effects of PFAS, offering a sustainable solution to reduce their impact on human health and ecosystems.
Funding
$540K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Per- and polyfluoroalkyl substances (PFAS) contaminate environments and pose risks to human health and ecosystems due to their persistence and harmful effects. Traditional methods of removing these substances are often costly and unsustainable.
Solution
Cambiotics develops precision probiotics engineered to detoxify PFAS from contaminated environments. This bioremediation approach offers a sustainable and targeted solution to reduce the impact of PFAS. By utilizing specifically designed probiotics, Cambiotics aims to break down PFAS molecules, effectively removing them from the environment and mitigating their harmful effects on human health and ecosystems. The technology provides a biological alternative to conventional chemical or physical remediation techniques.
Target Audience
Cambiotics targets environmental agencies, remediation companies, and industries responsible for PFAS contamination seeking sustainable and cost-effective solutions.
Features
- Engineered probiotics for targeted PFAS degradation
- Sustainable bioremediation approach
- Detoxification of various PFAS compounds
- Application in diverse contaminated environments (e.g., water, soil)